Hanlin Wang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
Papers in
-
- Protein Degradation and Inhibitors 9
- Ubiquitin and proteasome pathways 6
- Glycosylation and Glycoproteins Research 5
- RNA modifications and cancer 5
- Histone Deacetylase Inhibitors Research 4
- Oncology 14
- Co-authors
- Robert E. Scott (6 shared papers)John Hart (3 shared papers)Mark Birkenbach (2 shared papers)Zhenjie Ni (4 shared papers)Xiaotao Zhang (2 shared papers)Gang Chen (9 shared papers)Huanli Dong (3 shared papers)Jia Li (12 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)Advanced Materials (3 papers)OncoTargets and Therapy (3 papers)European Journal of Medicinal Chemistry (3 papers)Molecular and Cellular Biochemistry (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hanlin Wang
83 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 211
- Molecular Biology 618
- Gastroenterology 44
- Oncology 206
- Polymers and Plastics 101
Countries citing papers authored by Hanlin Wang
This map shows the geographic impact of Hanlin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanlin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanlin Wang more than expected).
Fields of papers citing papers by Hanlin Wang
This network shows the impact of papers produced by Hanlin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanlin Wang. The network helps show where Hanlin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hanlin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 129 | |
| 2 | 2010 | 129 | |
| 3 | 2021 | 64 | |
| 4 | 2000 | 56 | |
| 5 | 2018 | 50 | |
| 6 | 2021 | 45 | |
| 7 | 2012 | 44 | |
| 8 | 2023 | 38 | |
| 9 | 2023 | 37 | |
| 10 | 2022 | 35 | |
| 11 | 2020 | 34 | |
| 12 | 2016 | 33 | |
| 13 | 2017 | 28 | |
| 14 | 2015 | 28 | |
| 15 | 2022 | 27 | |
| 16 | 2017 | 27 | |
| 17 | 2017 | 24 | |
| 18 | 2018 | 24 | |
| 19 | Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma. | 2017 | 21 |
| 20 | 2016 | 20 |
About Hanlin Wang
Hanlin Wang is a scholar working on Molecular Biology, Oncology, Surgery, Hematology and Electrical and Electronic Engineering, having authored 94 papers that have together received 1.3k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (6 papers), MicroRNA in disease regulation (6 papers), Glycosylation and Glycoproteins Research (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Cancer Research (211 citations), Molecular Biology (618 citations), Gastroenterology (44 citations), Oncology (206 citations) and Polymers and Plastics (101 citations). Hanlin Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Robert E. Scott, John Hart, Mark Birkenbach, Zhenjie Ni, Xiaotao Zhang, Gang Chen, Huanli Dong, Jia Li, Qiang Zhao and Wenping Hu. Their work appears in journals such as Journal of Medicinal Chemistry, Advanced Materials, OncoTargets and Therapy, European Journal of Medicinal Chemistry and Molecular and Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.